DO YOU SHARE OUR VISION?
Neurotech is studying its lead product candidate, NT-501, in the orphan disease MacTel and in Glaucoma. Exciting challenges lie ahead as we prepare for BLA filling, and we will meet these challenges with the support of our dedicated team. We have just under thirty employees onsite in Cumberland, RI, approximately one-third of whom joined the company over ten years ago delivering MacTel treatment solutions, MacTel clinical trials, and MacTel Implant Encapsulated Cell Therapy.
We are eager to grow our team with employees who
share our company values and are interested in
developing with the company.
In addition to a competitive compensation package, Neurotech offers an innovative business casual environment and comprehensive benefits package including:
Competitive base salaries
401(k) Retirement Plan with company match
Short-Term and Long Term-Disability Insurance
Paid Vacation, Personal, Sick time and Holidays